SiriusPoint (SPNT) director awarded 5,903 restricted shares

Rhea-AI Filing Summary

SiriusPoint Ltd director Susan Lee Cross reported an equity award of 5,903 Common Shares on May 29, 2026. The shares were valued at $23.29 per share at grant and represent a compensation-related acquisition, not an open-market purchase.

After this grant, Cross directly holds 23,887 Common Shares, which include restricted shares. A portion of these restricted shares will vest in full on May 30, 2027, subject to her continued service as a director.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Cross Susan Lee

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Shares	5,903	$23.29	$137K

Holdings After Transaction: Common Shares — 23,887 shares (Direct, null)

Footnotes (1)

1. Includes restricted shares that vest in full on May 30, 2027, subject to the Reporting Person's continued service as a director of the Company. Includes Restricted Shares.

Key Figures

Share grant size: 5,903 shares Grant price per share: $23.29 per share Total holdings after grant: 23,887 shares +1 more

4 metrics

Share grant size 5,903 shares Common Shares awarded to director on May 29, 2026

Grant price per share $23.29 per share Value used for the Common Shares award

Total holdings after grant 23,887 shares Director’s direct Common Share holdings following the transaction

Restricted share vesting date May 30, 2027 Restricted shares vest in full subject to continued service

Key Terms

Common Shares, Restricted Shares, vest in full, continued service as a director

4 terms

Common Shares financial

"security_title: "Common Shares""

Common shares are the basic units of ownership in a company that give holders a claim on profits and a right to vote on key matters, like electing the board. Think of them as membership cards in a club: they let you share in successes and losses, but in a bankruptcy or liquidation they are paid after creditors and preferred shareholders, so their value can swing more and matters for assessing risk and potential return.

Restricted Shares financial

"Includes restricted shares that vest in full on May 30, 2027"

Restricted shares are company stock that cannot be sold or transferred immediately because they are subject to legal or contractual limits, such as a required holding period or performance conditions. They matter to investors because these locked-up shares can affect a company’s available stock for trading, future dilution, and insider incentives—imagine a gift that can’t be cashed until certain conditions are met, which changes when and how much supply can suddenly enter the market.

vest in full financial

"restricted shares that vest in full on May 30, 2027"

continued service as a director financial

"subject to the Reporting Person's continued service as a director"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cross Susan Lee

(Last) (First) (Middle)

POINT BUILDING, 3 WATERLOO LANE

(Street)

PEMBROKE HM08

(City) (State) (Zip)

BERMUDA

(Country)

2. Issuer Name and Ticker or Trading Symbol
SiriusPoint Ltd [ SPNT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/29/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	05/29/2026		A		5,903(1)	A	$23.29	23,887(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes restricted shares that vest in full on May 30, 2027, subject to the Reporting Person's continued service as a director of the Company.

2. Includes Restricted Shares.

Remarks:

Exhibit 24-Power Attorney

	/s/ Jacquelyne Belcastro, as Attorney-In-Fact for Susan Lee Cross	05/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did SiriusPoint (SPNT) director Susan Lee Cross report?

Susan Lee Cross reported receiving an award of 5,903 SiriusPoint Common Shares as compensation. The transaction is coded as a grant or award acquisition, indicating an equity-based award rather than an open-market stock purchase or sale.

How many SiriusPoint (SPNT) shares were granted to Susan Lee Cross?

She was granted 5,903 Common Shares of SiriusPoint Ltd. The filing notes a grant price of $23.29 per share, reflecting the value assigned at the time of the equity award for reporting purposes.

How many SiriusPoint (SPNT) shares does Susan Lee Cross hold after this grant?

Following the award, Susan Lee Cross directly holds 23,887 Common Shares of SiriusPoint. This figure includes restricted shares noted in the footnotes, some of which are scheduled to vest on a future date, subject to service conditions.

When do the restricted SiriusPoint (SPNT) shares reported by Susan Lee Cross vest?

The filing states that certain restricted shares vest in full on May 30, 2027. Vesting is conditioned on Cross’s continued service as a director of SiriusPoint Ltd through that date, aligning the award with ongoing board service.

Is the SiriusPoint (SPNT) transaction by Susan Lee Cross a market purchase?

No, the transaction is an equity grant or award, not a market purchase. It is coded as an acquisition through a grant, meaning the shares were awarded as part of compensation rather than bought on the open market.